Data Integrity

Eolus has extensive experience helping our clients to understand and comply with Electronic Records & Electronic Signatures regulations. Our consultants stay abreast with the latest FDA guidance for Data Integrity. Our services range in scope from Audits, Training, Risk Assessments, Software Evaluations, Project Planning & Management, to Software Validation projects to ensure compliance of software applications, systems and infrastructure. We provide end to end data integrity assessments and reviews.

Standards and References

  • FDA Glossary of Computerized System and Software Development Terminology
  • General Principles of Software Validation; Final Guidance for Industry, FDA
  • Data Integrity and Compliance, FDA
  • GAMP 5, A Risk-Based Approach to Compliant GXP Computerized Systems, 2nd Edition
  • Good Documentation Practices (GDP)
  • GAMP Data Integrity Guide
  • International Conference on Harmonization (ICH) E6, Good Clinical Practices (GCPs)
  • Pharmaceutical Inspection Co-operation Scheme (PIC/S) Guidance for Computerized Systems
  • 21 CFR 11, Electronic Records; Electronic Signatures
  • 21 CFR 312, Investigational New Drug Application
  • 21 CFR 50, Protection of Human Subjects
  • 21 CFR 54 Financial Disclosure by Clinical Investigators
  • 21 CFR 56 Institutional Review Boards (IRB)
  • 21 CFR 211 Current Good Manufacturing Process (cGMP)
  • 21 CFR 820, Quality  System Regulation (QSR)
  • 21 CFR Part 58, Good Laboratory Practices (GLP)
  • ISO 27001: Information Security Management System (ISMS)
  • ISO 27701: Information Security, Cybersecurity, Privacy
  • ISO 13485: Quality Management System (QMS)
  • ISO 14971: Medical Devices, Application of Risk Management
  • ICH Q9 (R1) Pharmaceutical Risk Management
  • ICH Q10 Pharmaceutical Quality System
  • ICH E6 (R3), Good Clinical Practices (GCP)
  • IEC 62304 Medical Device Software, Software Lifecycle 
  • EU Good Data Privacy Regulation (GDPR)
  • EU GMP Annex 11, Computerized Systems
  • PICs/GOOD PRACTICES FOR DATA MANAGEMENT AND INTEGRITY IN REGULATED GMP/GDP ENVIRONMENTS
  • EMA Guideline on Computerized systems and electronic data in clinical trials
  • Medicine & Healthcare Products Regulatory Agency (MHRA) ‘GXP’ Data Integrity Guidance and Definitions

Key Industry Association Presentations

  • DIA Conference on EDC-October 1999: Electronic Data Capture;a Lotus on Onion Blossom?”
  • Fraser Williams Users Group Meeting – May 2000: “To Validate or not to Validate, That is the Question”
  • Barnett & PDA/FDA conference – June 2000: “Electronic Records: Real Life Scenarios”
  • PDA Annual Meeting – Dec 2000: A Project Management Approach to Compliance Programs”
  • DIA Annual Meeting – July 2001: IVR Case Study for Success”

Patents

US Patent serial number 10/132,537 (Weldon et al) filed April 25, 2002, related to systems, methods and computer program products for designing, deploying and managing interactive voice response (IVR) systems for Clinical Research – April, 2002

Key Publications

  • “Electronic Records: An “IVR Cast Study for Success”. Quality Assurance Journal, volume 6, issues 2 – June 2002, Wiley & Sons, LTD.
  • Good Practice and Compliance for Electronic Records and Signatures (Part 1) Good Electronic Records Management (GERM)“, CoAuthor and PDA Task Force member, 2002
  • Good Practice and Compliance for Electronic Records and Signatures (Part 2) Complying with 21 CFR Part 11, Electronic Records and Signatures“, GAMP Forum, PDA Task Force, 2001
  • “Good Practice and Compliance for Electronic Records and Signatures (Part 3) Models for Systems Implementation and Evolution“, CoAuthor and PDA Task Force member, 2004
  • “Current Concepts in Validation and Compliance, Computerized Systems Used in Non Clinical Safety Assessment”; GLP, DIA RED Apple II Committee Member, Collaborator and Co-Author. 2007  
  • “System and Data Integrity for Clinical Trials”; GCP, DIA Peach Committee member and Co-Author, 2008
  • Good Clinical Practice, A Question and Answer Guide, Section 10, FDA inspections, Quality Assurance Activities, and Study Auditing, 2020 CoEditor with Earl Hulihan, Section 10

Current and Previous Professional Associations

  • ASQ, American Society of Quality
  • CDISC, Clinical Data Interchange Standards Consortium
  • DIA, Drug Information Association
  • PDA, Parental Drug Association
  • Medical Device Engineers and Consultants
  • NCCSQA; NC Society of Quality Associates
  • TTEC, Triangle Technology Executive Committee 
  • ANSI RAB Accredited ISO9001 Lead Auditor 
  • PDA/ARC Computer Supplier Auditor Certificate #1064                       
  • Triangle PEERS: Electronic Records/Data Integrity

Scroll to Top